Advertisement

Topics

‘Explosive demand’ for primate research drives Alpha Genesis expansion in Europe

13:40 EDT 12 Jul 2018 | Outsourcing-Pharma

Alpha Genesis is investing more than $2m in its European operations to help meet a demand for Zika, Ebola, and flu vaccine development.

Original Article: ‘Explosive demand’ for primate research drives Alpha Genesis expansion in Europe

NEXT ARTICLE

More From BioPortfolio on "‘Explosive demand’ for primate research drives Alpha Genesis expansion in Europe"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...